Log In
BCIQ
Print this Print this
 

Interleukin-2 (IL-2) receptor alpha chain (CD25)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-2 (IL-2) receptor alpha chain (CD25)

BCIQ
Print ChartPrint this
Marketed, 1 Registration, 1 Phase I, 1
Phase of DevelopmentPhase IRegistrationMarketed
Autoimmune

-

1

-

Cancer

1

-

-

Transplant

-

-

1




 Products Targeting Interleukin-2 (IL-2) receptor alpha chain (CD25)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$1,391.3M

$1,391.3M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today